Evidence map›Paper›PMID 40267221›Full record

ArticleBlood advances2025

T-cell dysfunction during blinatumomab therapy in pediatric acute lymphoblastic leukemia.

Julie Ma, Annie Luong, Andrew Doan, Tsen Yin Lin, Lingyun Ji, Cassandra P Wang, Seon-Jae Yoon, Teresa Rushing, Anh Duong, Miguel Villa and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Julie MaCancer and Blood Disease Institute, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA.ORCID 0000-0003-4393-2927
Annie LuongThe Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA.
Andrew DoanCancer and Blood Disease Institute, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA.ORCID 0000-0002-8362-549X
Tsen Yin LinThe Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA.
Lingyun JiDepartment of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA.ORCID 0000-0003-2500-1993
Cassandra P WangCancer and Blood Disease Institute, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA.ORCID 0000-0001-8000-7939
Seon-Jae YoonCancer and Blood Disease Institute, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA.
Teresa RushingCancer and Blood Disease Institute, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA.
Anh DuongThe Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA.
Miguel VillaCancer and Blood Disease Institute, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA.
Chintan ParekhCancer and Blood Disease Institute, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40267221
PMCPMC12305223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.